Breaking News: Medera Inc. to Join NASDAQ via Merger with Keen Vision Acquisition Corporation

Medera: Revolutionizing Cardiovascular Disease Treatment Introduction Medera, a clinical-stage biotechnology company, is at the forefront of targeting difficult-to-treat cardiovascular diseases. Their focus on next-generation gene- and cell-based approaches, in combination with bioengineered human mini-heart drug discovery and screening technology platforms, sets them apart in the field of biotech innovation. Merger and Growth The recent merger…

Read More

Levi and Korsinsky Investigates Universal on Behalf of Business and Professional Services

Levi & Korsinsky Investigates Universal Display Corporation for Possible Securities Violations New York, NY / ACCESS Newswire / January 24, 2025 Levi & Korsinsky has recently announced that it is launching an investigation into Universal Display Corporation (NASDAQ:OLED) for potential violations of federal securities laws. The investigation comes on the heels of Universal’s solid 2Q…

Read More

“Seeking Recovery for Lost Investments: Join the Class Action Suit Against Regeneron Pharmaceuticals with The Gross Law Firm”

Welcome to The Gross Law Firm Blog A Message to Shareholders of Regeneron Pharmaceuticals, Inc. Dear Shareholders, Today, we are reaching out to you with an important notice regarding Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). As of January 23, 2025, The Gross Law Firm is issuing a notice to all shareholders who purchased shares of REGN…

Read More

Uncovering the Most Wanted Malware of February 2023: The Remcos Trojan’s Connection to Cyberespionage Against the Ukrainian Government

February 2023’s Most Wanted Malware Remcos Trojan Linked to Cyberespionage Operations Against Ukrainian Government Entities San Carlos, Calif., March 09, 2023 (GLOBE NEWSWIRE) — Check Point® Researchers have recently reported that the Remcos Trojan was utilized by threat actors to target Ukrainian government entities through sophisticated phishing attacks. These attacks were part of wider cyberespionage…

Read More